InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
4
T+90 hit rate
11%
T+90 mean return
-31.9%
Across 19 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by KIDRON NADAV, Chairman & CEO. Insider active across 1 company, notably Oramed Pharmaceuticals INC.. In total, 26 filings have been recorded. Breakdown: 2 buys · 4 sells. Total volume traded: €15.3m. History available since 9 August 2021. The latest transaction was filed on 11 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations26 total
141,000 shares0Common StockSEC:0001213900-25-012239:0
433,500 sharesCommon StockSEC:0001213900-25-001168:0
45,000 sharesCommon StockSEC:0001213900-24-095931:0
329,000 sharesCommon StockSEC:0001209191-24-001151:0
120,000 sharesCommon StockSEC:0001209191-23-033145:0
279,000 sharesCommon StockSEC:0001209191-23-024939:0
26,000 shares@ US$2.0390.3% of flowCommon StockSEC:0001209191-23-019367:0
Ideal exit: 11 Dec 2023 (T+270)
100,000 shares@ US$2.011.2% of flowCommon StockSEC:0001209191-23-018956:0
Ideal exit: 9 Dec 2023 (T+270)
25,000 shares0Common StockSEC:0001209191-22-054879:0
34,000 sharesCommon StockSEC:0001209191-22-043768:0
150,000 sharesCommon StockSEC:0001213900-22-001613:0
150,000 sharesCommon StockSEC:0001213900-22-001613
150,000 sharesCommon StockSEC:0001213900-22-000818
150,000 sharesCommon StockSEC:0001213900-22-000818:0
31,728 shares@ US$12.982.3% of flowCommon StockSEC:0001213900-21-068231
31,728 shares@ US$12.980.32% mcap2.3% of flowCommon StockSEC:0001213900-21-068231:0
100,000 sharesCommon StockSEC:0001213900-21-063944:0
100,000 sharesCommon StockSEC:0001213900-21-063944
220,000 shares@ US$20.105223.5% of flowCommon StockSEC:0001213900-21-063945
20,000 sharesCommon StockSEC:0001213900-21-063983
220,000 shares@ US$20.10523.37% mcap23.8% of flowCommon StockSEC:0001213900-21-063945:0
20,000 sharesCommon StockSEC:0001213900-21-063983:0
100,000 sharesCommon StockSEC:0001213900-21-046407
100,000 sharesCommon StockSEC:0001213900-21-046407:0
220,000 shares@ US$20.10523.37% mcap23.8% of flowCommon StockSEC:0001213900-21-041711:0
25 of 26 declarations
About KIDRON NADAV
Nadav Kidron is an executive at Oramed Pharmaceuticals Inc.
